Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...
GlobalData on MSN1mon
Globus Medical strengthens SCS market position with $250m Nevro dealBoston Scientific’s Wavewriter spinal cord stimulator systems, for example, gained access to a wider market after winning FDA approval for non-surgical back pain in February 2024. Looking ahead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results